Drawing for ELLENNBE

USPTO serial 79345349

ELLENNBE

Reviewed by CopyMark Law Group

Reg. 7601776Status 700Registered
Filing date
Status date
Registration date
Dec 17, 2024
Examiner
MCCAULEY, BRENDAN D
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ELLENNBE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

GABRIELLE S. ROTH

GABRIELLE S. ROTH SUGHRUE MION, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000WASHINGTON, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
005Dressings, medical; adhesive skin patches for medical use; heating patches for medical purposes; adhesive plasters for medical purposes; pharmaceutical preparations for regulating the immune system, pharmaceutical preparations for the treatment of autoimmune disorders and autoimmune diseasesACTIVE—
010Hypodermic injection apparatus, namely, hypodermic syringes and hypodermic needles filled with immunomodulatory drugs or peripheral blood mononuclear cellsACTIVE—
042Research and development of vaccines and medicines; bacteriological research and analysis; biological research, clinical research, namely, medical and scientific research in the nature of conducting clinical trials for others, and medical research; pharmaceutical products development; biological research; biochemical analysis; biological analysis; laboratory research services relating to dermatology; pharmaceutical drug development services; research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development of new products; research and development services in the field of antibodies; research relating to biotechnology; research to develop new products; biological research and analysis; biomedical research services; design and product development of medical technology; design and development of medical technology, namely, software design and development for medical technology; scientific research in the field of pharmacy; product development of pharmaceutical preparations and medicines; pharmaceutical research services; biotechnological research relating to livestock, namely, research in the field of gene editing technology and biological research in the field of livestock; pharmaceutical research and development; bacteriological analysis; medical research; development of new products; biochemical research and analysis; research on the subject of pharmaceuticals; biological analysis in the field of molecular biology; none of the foregoing services related to lasers, laser medicine, or laser medical researchACTIVE—
045Licensing of patents; granting of licenses to others for the use of industrial property rights and copyright; licensing of intellectual property; licensing of patents, computer software and intellectual property in the field of technologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 19, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 19, 2025FIMPFINAL DISPOSITION PROCESSED—
Mar 17, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 17, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 17, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 15, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 15, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 9, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 26, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 26, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 26, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 13, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 27, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 27, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 9, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 9, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Aug 9, 2023CNSLSUSPENSION LETTER WRITTEN—
Aug 2, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 2, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 2, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 19, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 19, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 19, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 19, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 19, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 19, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 6, 2023RFNTREFUSAL PROCESSED BY IB—
Feb 26, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 11, 2023CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 8, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 8, 2023RFRRREFUSAL PROCESSED BY MPU—
Dec 14, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 13, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2022DOCKASSIGNED TO EXAMINER—
Jul 26, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 21, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance